This steady-state approach often leads to more predictable results than oral forms, which have lower absorption rates
Compounded semaglutide contains the same active ingredient as name-brand versions, and while large-scale clinical trials have not been conducted due the relatively recent adoption of GLP-1 medications, many patients report positive results
Before Zepbound Existed: Mounjaro was the only tirzepatide option available from May 2022 until November 2023 when Zepbound received FDA approval for weight loss
Results Patient population We included 78,781 patients who had both a prescription for a GLP-1 receptor agonist (GLP-1 RA) and a documented reason for discontinuing the medication between June 2021 and December 2024 (Table 1)
Start your free visit today to explore hair, skin, and sexual health products, and more
Approximately 40% of adults prescribed GLP-1 receptor agonists also take selective serotonin reuptake inhibitors (SSRIs) like Lexapro for depression or anxiety
